BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37555417)

  • 1. Symmetric drug-related intertriginous and flexural exanthema due to super-bioavailable itraconazole.
    Dhabal A; Das NK; Sil A
    Indian J Pharmacol; 2023; 55(3):192-193. PubMed ID: 37555417
    [No Abstract]   [Full Text] [Related]  

  • 2. Itraconazole-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE): a rare occurrence.
    Kalita BJ; Das S; Dutta B
    Int J Dermatol; 2020 Nov; 59(11):e419-e421. PubMed ID: 32767394
    [No Abstract]   [Full Text] [Related]  

  • 3. Rare case of itraconazole induced SDRIFE (symmetrical drug-related intertriginous and flexural exanthema).
    Koschitzki K; Karrer S; Berneburg M; Niebel D; Drexler K
    J Dtsch Dermatol Ges; 2024 Jun; 22(6):833-836. PubMed ID: 38567643
    [No Abstract]   [Full Text] [Related]  

  • 4. Levofloxacin-induced symmetric drug-related intertriginous and flexural exanthema.
    Tsai YW; Chung WH; Wang CW; Cheng CY
    Contact Dermatitis; 2022 Jan; 86(1):64-66. PubMed ID: 34553784
    [No Abstract]   [Full Text] [Related]  

  • 5. Rising trends of symmetrical drug related intertriginous and flexural exanthem due to Itraconazole in patients with superficial dermatophytosis: A case series of 12 patients from eastern part of India.
    Hassanandani T; Panda M; Agarwal A; Das A
    Dermatol Ther; 2020 Nov; 33(6):e13911. PubMed ID: 32594647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First Case of Symmetric Drug-Related Intertriginous and Flexural Exanthema Induced by Meropenem.
    Blanco Garcia-Granero D; Barranco R; García-Moguel I; Velasco V; Diéguez Pastor MC
    J Investig Allergol Clin Immunol; 2021 Dec; 31(6):516-517. PubMed ID: 33661103
    [No Abstract]   [Full Text] [Related]  

  • 7. Symmetric drug-related intertriginous and flexural exanthema-like eruption related to coronavirus disease 2019 vaccine.
    Hong JK; Shin SH; Yoo KH; Li K; Seo SJ
    Contact Dermatitis; 2022 Jul; 87(1):91-93. PubMed ID: 35243643
    [No Abstract]   [Full Text] [Related]  

  • 8. Symmetric Drug-Related Intertriginous and Flexural Exanthema.
    Mansilla Polo M; Martín-Torregrosa D
    N Engl J Med; 2024 Feb; 390(7):e17. PubMed ID: 38354144
    [No Abstract]   [Full Text] [Related]  

  • 9. Symmetrical drug-related intertriginous and flexural exanthema caused by valacyclovir.
    Daito J; Hanada K; Katoh N; Katoh S; Sakamoto K; Asai J; Takenaka H; Kishimoto S
    Dermatology; 2009; 218(1):60-2. PubMed ID: 18974630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions.
    Winnicki M; Shear NH
    Am J Clin Dermatol; 2011 Jun; 12(3):171-80. PubMed ID: 21469762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symmetrical drug-related intertriginous and flexural exanthema due to ranitidine.
    Binitha MP; Sasidharanpillai S; John R; Sherjeena PV
    Indian J Pharmacol; 2014; 46(5):551-2. PubMed ID: 25298589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remifentanil-Induced Symmetric Drug-Related Intertriginous and Flexural Exanthema: A Diagnostic Challenge in an Intensive Care Patient.
    Martins JF; Alen Coutinho I; Castro M; Carvalho J; Faria C; Sousa E; Martins P
    J Investig Allergol Clin Immunol; 2022 Oct; 32(5):399-401. PubMed ID: 34779773
    [No Abstract]   [Full Text] [Related]  

  • 13. Maculopapular eruption secondary to itraconazole.
    Batinac T; Zamolo G; Troselj-Vukić B; Biljan D; Petranović D; Kujundzić M
    Coll Antropol; 2008 Jun; 32(2):649-51. PubMed ID: 18756926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paracetamol-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) in a psoriasis patient receiving apremilast therapy.
    Megna M; Cinelli E; Napolitano M; Fabbrocini G; Patruno C
    Contact Dermatitis; 2019 Dec; 81(6):451-454. PubMed ID: 31328275
    [No Abstract]   [Full Text] [Related]  

  • 15. Systemic drug-related intertriginous and flexural exanthema (SDRIFE).
    Elmariah SB; Cheung W; Wang N; Kamino H; Pomeranz MK
    Dermatol Online J; 2009 Aug; 15(8):3. PubMed ID: 19891911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symmetric drug-related intertriginous and flexural exanthema: Clinicopathologic study of 19 cases and review of literature.
    Schuler AM; Smith EH; Chaudet KM; Bresler SC; Gudjonsson JE; Kroshinsky D; Nazarian RM; Chan MP
    J Cutan Pathol; 2021 Dec; 48(12):1471-1479. PubMed ID: 34159622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symmetrical drug-related intertriginous and flexural exanthema due to codeine.
    Erfan G; Yanik ME; Kaya S; Tasolar K; Oznur M; Kulac M
    Indian J Dermatol Venereol Leprol; 2015; 81(4):405-6. PubMed ID: 26087105
    [No Abstract]   [Full Text] [Related]  

  • 18. Symmetrical drug-related intertriginous and flexural exanthema induced by clarithromycin.
    Moreira C; Cruz MJ; Cunha AP; Azevedo F
    An Bras Dermatol; 2017; 92(4):587-588. PubMed ID: 28954125
    [No Abstract]   [Full Text] [Related]  

  • 19. Symmetrical drug-related intertriginous and flexural exanthema like eruption associated with COVID-19 vaccination.
    Lim PN; Wylie G
    Clin Exp Dermatol; 2022 Jan; 47(1):175-176. PubMed ID: 34399001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute generalized exanthematous pustulosis induced by itraconazole.
    Park YM; Kim JW; Kim CW
    J Am Acad Dermatol; 1997 May; 36(5 Pt 1):794-6. PubMed ID: 9146550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.